Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,000
Closed -$56K 5885
2020
Q1
$56K Buy
1,000
+800
+400% +$60.8K ﹤0.01% 5161
2019
Q4
$17K Buy
+200
New +$15.7K ﹤0.01% 6014
2013
Q4
Sell
-11,400
Closed -$479K 7603
2013
Q3
$479K Buy
11,400
+7,900
+226% +$323K ﹤0.01% 4166
2013
Q2
$149K Buy
+3,500
New +$149K ﹤0.01% 5456

Other funds holding ITRI

Barclays's ITRI Position: Q1 2026 in Review

Barclays reduced its Itron (ITRI) stake by 18% in Q1 2026, selling an estimated $1.26M and leaving 57,792 shares worth $5.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1799.

Barclays first reported a position in ITRI in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.1M in Q2 2025. 432 funds tracked by Wall St. Rank hold ITRI as of Q1 2026.

  • Barclays held 57,792 shares of Itron worth $5.18M as of Q1 2026.
  • Barclays sold 13,090 Itron shares in Q1 2026, an estimated $1.26M.
  • Itron made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1799 holding.
  • Barclays first reported a position in Itron in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Itron position peaked at $12.1M in Q2 2025.
  • 432 funds tracked by Wall St. Rank held Itron as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.